Gedeon Richter - Articles and news items

Ulipristal acetate meets primary endpoints in uterine fibroid study

Industry news / 9 May 2016 / Victoria White, Digital Content Producer

Allergan and Richter have announced positive results from Venus I, evaluating the efficacy and safety of ulipristal acetate in women with uterine fibroids…

FDA approves Vraylar for schizophrenia and bipolar disorder

Industry news / 21 September 2015 / Victoria White

The FDA approval is based on the results of three 3-week controlled trials in adults with bipolar I disorder and three 6-week placebo-controlled trials in adults with schizophrenia…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+